Acadia Healthcare Company Inc
NASDAQ: ACHC · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-04-29
Acadia Healthcare Company Inc (ACHC) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for ACHC.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
ACHC historical valuation range
Where current P/E sits in ACHC's own 5Y range.
ACHC intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
ACHC valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 0.79x
Is ACHC overvalued in 2026?
Acadia Healthcare Company Inc (ACHC) currently trades at $28.26 per share with a market capitalization of $2,600,887,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 49/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
ACHC currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 0.8x, the market is valuing the company primarily on its revenue rather than its earnings.
Looking at its own history, ACHC is currently trading cheaper than 100% of the last 5Y on P/E. This places it in the 0th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates ACHC's intrinsic value at $143.95 per share, against the current market price of $28.26. This implies a margin of safety of +89.21%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 2/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: ACHC appears richly valued on our framework, with a Smart Value Score of 49/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is ACHC overvalued in 2026?
Based on a Smart Value Score of 49/100, ACHC appears overvalued. Current price exceeds what fundamentals currently justify.
What is ACHC's fair value?
Our DCF model estimates ACHC's intrinsic value at $143.95 per share, versus the current price of $28.26. This produces a margin of safety of +89.21%.
What P/E ratio does ACHC trade at?
ACHC does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.
Is ACHC a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 49/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does ACHC's valuation compare to its history?
On P/E, ACHC currently sits in the 0th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is ACHC's Smart Value Score?
ACHC's Smart Value Score is 49/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.